Healthcare Triangle is trading at $5.15, down 18.30%, as software-sector weakness is the likeliest explanation for its October 30 pre-market decline, though no direct link is confirmed.
- No fresh company-specific announcement explaining the decline surfaced in the search.
- Its latest major news was a 1-for-20 reverse stock split, effective October 26, under a Nasdaq compliance plan; it predates the decline.
- Software shares and major U.S. indexes were sharply lower in the supplied market context.